Tesaro, Inc. (Waltham, Massachusetts)
309 Waverley Oaks Road
Suite #101
Waltham
Massachusetts
02452
United States
Tel: 339-970-0900
Website: http://tesarobio.com/
230 articles about Tesaro, Inc. (Waltham, Massachusetts)
-
TESARO's Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year
11/20/2017
They were also recognized as the National Award Winners in the Life Sciences category.
-
TESARO Announces European Commission Approval of ZEJULA for Women With Recurrent Ovarian Cancer
11/20/2017
ZEJULA was approved by the FDA on March 27, 2017 and is marketed by TESARO in the United States.
-
TESARO Announces Third-Quarter 2017 Operating Results
11/8/2017
TESARO reported total revenue of $142.8 million for the third quarter of 2017, compared to $17.0 million for the third quarter of 2016.
-
TESARO Announces U.S. FDA Approval of VARUBI IV for Delayed Nausea and Vomiting Associated With C...
10/26/2017
VARUBI IV is supplied in ready-to-use vials and does not require refrigerated storage or mixing. -
Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents
10/26/2017
Evotec and TESARO today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology (IO) target.
-
TESARO to Announce Third-Quarter 2017 Financial Results on November 7, 2017
10/25/2017
This quarterly earnings call will be available via phone and webcast.
-
The Foundation for Women's Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women's Cancer
10/18/2017
TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer.
-
Tesaro Expands Our Way Forward Program For The Ovarian Cancer Community And Partners With Olympic Gymnast Shannon Miller
9/29/2017
-
Tesaro Receives Positive CHMP Opinion For ZEJULA
9/15/2017
-
Tesaro Summarizes ZEJULA And TSR-042 Data Presented At The 2017 ESMO Annual Meeting
9/11/2017
-
Tesaro Announces Nine Data Presentations At The 2017 European Society For Medical Oncology (ESMO) Annual Meeting
8/25/2017
-
Tesaro Announces Participation at Four Investor Conferences
8/24/2017
-
Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA
8/18/2017
-
Tesaro Announces Second-Quarter 2017 Operating Results
8/9/2017
-
Tesaro To Announce Second-Quarter 2017 Financial Results On August 8, 2017
7/26/2017
-
STA Pharmaceutical Signs Supply Agreement With Tesaro
7/24/2017
-
Sources Reveal Tesaro is Unlikely to Find a Buyer
7/17/2017
-
Tesaro Joins OCRFA As Presenting Sponsor Of The 2017 Ovarian Cancer National Conference
6/29/2017
-
Tesaro Announces Lonnie Moulder And Mary Lynne Hedley Named Ey Entrepreneurs Of The Year New England
6/28/2017
-
Tesaro Joins Healthcare Businesswomen's Association As Corporate Partner
6/27/2017